| scholarly article | Q13442814 |
| P50 | author | Anne Ulrich | Q4768858 |
| Marina Berditsch | Q57124010 | ||
| Sergii Afonin | Q42199053 | ||
| Parvesh Wadhwani | Q46428968 | ||
| P2093 | author name string | Tatiana Vladimirova | |
| P2860 | cites work | Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis | Q24625342 |
| Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies | Q50557919 | ||
| Purification and composition of Ca2+/Mg2+ ATPase from rat heart plasma membrane | Q50800226 | ||
| Functional Synergism of the Magainins PGLa and Magainin-2 in Escherichia coli, Tumor Cells and Liposomes | Q57393932 | ||
| 19F NMR Analysis of the Antimicrobial Peptide PGLa Bound to Native Cell Membranes from Bacterial Protoplasts and Human Erythrocytes | Q57528427 | ||
| Solid State NMR Structure Analysis of the Antimicrobial Peptide Gramicidin S in Lipid Membranes: Concentration-Dependent Re-alignment and Self-Assembly as a β-Barrel | Q57528476 | ||
| Magainins as paradigm for the mode of action of pore forming polypeptides | Q77521430 | ||
| Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
| The viable but nonculturable state in bacteria | Q28239571 | ||
| Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
| Persister cells | Q30018300 | ||
| Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics | Q33496165 | ||
| Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli | Q33534627 | ||
| Diversity of antimicrobial peptides and their mechanisms of action | Q33789705 | ||
| How do bacteria resist human antimicrobial peptides? | Q34575973 | ||
| A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli | Q34818566 | ||
| Effect of subinhibitory antimicrobial concentrations (sub-MICs) on in-vitro bacterial adherence to uroepithelial cells | Q35737792 | ||
| Survival strategies of infectious biofilms | Q36003660 | ||
| Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections | Q36422855 | ||
| The small colony variant (SCV) concept -- the role of staphylococcal SCVs in persistent infections | Q36465046 | ||
| Complexation and phase transfer of nucleotides by gramicidin S. | Q36591851 | ||
| Multifunctional antimicrobial peptides: therapeutic targets in several human diseases | Q36704656 | ||
| Antimicrobial peptides: natural effectors of the innate immune system | Q36875869 | ||
| Characterization of clinical Enterococcus faecalis small-colony variants | Q37333583 | ||
| Synergistic transmembrane insertion of the heterodimeric PGLa/magainin 2 complex studied by solid-state NMR. | Q37409630 | ||
| Bacterial sensing of antimicrobial peptides | Q37421363 | ||
| Resistance to polymyxins: Mechanisms, frequency and treatment options | Q37789063 | ||
| Antibiotic-induced biofilm formation | Q37957603 | ||
| Designing antimicrobial peptides: form follows function. | Q37968899 | ||
| Modulating immunity as a therapy for bacterial infections | Q37994068 | ||
| Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa | Q39475655 | ||
| Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects | Q40311898 | ||
| Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR. | Q40329241 | ||
| Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically | Q40996709 | ||
| Deciphering the mode of action of the synthetic antimicrobial peptide Bac8c | Q41842977 | ||
| Conformation and membrane orientation of amphiphilic helical peptides by oriented circular dichroism | Q41889885 | ||
| Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy. | Q42001776 | ||
| Interaction of cationic antimicrobial peptides with model membranes | Q43687963 | ||
| Temperature-dependent transmembrane insertion of the amphiphilic peptide PGLa in lipid bilayers observed by solid state 19F NMR spectroscopy | Q46428881 | ||
| Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa | Q46725670 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| P304 | page(s) | 222 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Antimicrobial Peptides can Enhance the Risk of Persistent Infections | |
| P478 | volume | 3 |
| Q91559076 | Supreme activity of gramicidin S against resistant, persistent and biofilm cells of staphylococci and enterococci |
| Q41159517 | Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. |
| Q54490392 | The biofilm, injectables, and cosmetic dermatology. |
Search more.